BIO-RAD LABORATORIES, INC. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Bio Rad Laboratories, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $64.5M, a 29.1% decline year-over-year.
  • Bio Rad Laboratories, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $306M, a 15.3% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2023 was $338M, a 30% decline from 2022.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2022 was $483M, a 3.54% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2021 was $500M, a 18.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $306M $64.5M -$26.5M -29.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $332M $101M +$11.9M +13.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $321M $44.7M -$17.2M -27.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $338M $95.3M -$23.4M -19.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $361M $90.9M -$3.7M -3.91% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $365M $89.6M -$33.3M -27.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $398M $61.9M -$84.5M -57.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $483M $119M +$782K +0.66% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $482M $94.6M -$62.2M -39.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $544M $123M -$1.89M -1.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $546M $146M +$45.5M +45.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $500M $118M -$67.7M -36.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $568M $157M +$47.2M +43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $521M $125M +$73M +141% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $448M $101M +$26.5M +35.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $421M $186M +$126M +214% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $295M $110M +$52.1M +90.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $243M $51.7M -$4.65M -8.24% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $247M $74.4M +$17.8M +31.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $230M $59.2M +$286M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 -$56.6M $57.5M +$21.2M +58.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$77.8M $56.4M +$12.6M +28.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$90.4M $56.6M +$13M +29.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$103M -$227M -$273M -595% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $170M $36.3M -$2.49M -6.42% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $172M $43.8M +$45.5M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $127M $43.6M +$17.4M +66.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $109M $45.9M +$74.1M Oct 1, 2017 Dec 31, 2017 10-K 2018-04-16
Q3 2017 $35.1M $38.8M +$16.1M +70.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $19M -$1.7M -$28.6M -106% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $47.6M $26.2M +$6.01M +29.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $41.6M -$28.2M -$87.7M -147% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $129M $22.7M -$9.97M -30.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-16
Q2 2016 $139M $26.9M -$13.3M -33.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-16
Q1 2016 $153M $20.2M -$14.1M -41.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-16
Q4 2015 $167M $59.5M +$8.9M +17.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-16
Q3 2015 $158M $32.7M -$569K -1.71% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $158M $40.2M -$5.48M -12% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $164M $34.3M +$13.9M +67.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $150M $50.6M -$1.73M -3.31% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $152M $33.2M +$4.18M +14.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $148M $45.7M -$7.24M -13.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $155M $20.5M -$14.7M -41.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $169M $52.3M -$18.3M -26% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $188M $29.1M -$36.8M -55.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $225M $52.9M -$20.4M -27.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $245M $35.2M -$19.2M -35.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $264M $70.7M -$25.4M -26.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $290M $65.8M -$8.08M -10.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $298M $73.3M +$5.12M +7.51% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $292M $54.4M -$12.8M -19% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $305M $96M +$18.2M +23.4% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-18
Q3 2011 $287M $73.9M -$880K -1.18% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $288M $68.2M +$10K +0.02% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $288M $67.1M +$3.87M +6.12% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $284M $77.8M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-18
Q3 2010 $74.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $68.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $63.2M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.